Skip to main content

Eugeni Bruguera Cortada

Institutions of which they are part

Senior researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Eugeni Bruguera Cortada

Institutions of which they are part

Senior researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Projects

An effectiveness and safety study of varenicline for smoking cessation in hospitalized patients with psychiatric disorders

IP: Eugeni Bruguera Cortada
Collaborators: -
Funding agency: Pfizer Inc
Funding: 90196.52
Reference: VARENICLINE_WI231379-PFIZER2017
Duration: 29/01/2018 - 01/04/2020

Related news

The European project DISCOvERIE, led by Vall d’Hebron, paves the way for more personalized diagnoses and new treatment strategies to improve patients’ quality of life.

The meeting takes place within the framework of Healing Arts Barcelona, with the aim of exploring and debating how participation in artistic activities can help improve physical and mental health.

Genetic susceptibility to developing ADHD shows the strongest association with mental health problems during childhood and adolescence, compared to genetic risk for other psychiatric conditions.

Related professionals

Marc Rivas Agudo

Marc Rivas Agudo

Diabetes and Metabolism
Read more
Anna  Pascual  Carreño

Anna Pascual Carreño

Predoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more
Eudald  Castell Panisello

Eudald Castell Panisello

Research technician
Psychiatry, Mental Health and Addictions
Read more
Miriam Martos Fernández

Miriam Martos Fernández

New Technologies and Craniofacial Microsurgery
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.